Geode Capital Management, LLC Ironwood Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,293,542 shares of IRWD stock, worth $14.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,293,542

Previous 3,372,322 2.34%

Holding current value

$14.7 Million

Previous $22 Million 38.44%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.93 - $7.04 $309,605 - $554,611	-78,780 Reduced 2.34%	3,293,542 $13.5 Million
Q2 2024 Aug 09, 2024	BUY	$5.58 - $8.61 $1.26 Million - $1.94 Million	225,164 Added 7.15%	3,372,322 $22 Million
Q1 2024 May 13, 2024	BUY	$8.32 - $15.45 $554,902 - $1.03 Million	66,695 Added 2.17%	3,147,158 $27.4 Million
Q4 2023 Feb 13, 2024	BUY	$8.79 - $11.51 $1.37 Million - $1.8 Million	156,340 Added 5.35%	3,080,463 $35.2 Million
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $1.09 Million - $1.5 Million	131,838 Added 4.72%	2,924,123 $28.2 Million
Q2 2023 Aug 11, 2023	BUY	$10.1 - $11.6 $1.6 Million - $1.84 Million	158,481 Added 6.02%	2,792,285 $29.7 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $1.23 Million - $1.49 Million	118,514 Added 4.71%	2,633,804 $27.7 Million
Q4 2022 Feb 13, 2023	BUY	$9.9 - $12.43 $491,663 - $617,311	49,663 Added 2.01%	2,515,290 $31.2 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $1.52 Million - $1.85 Million	-149,412 Reduced 5.71%	2,465,627 $25.5 Million
Q2 2022 Aug 12, 2022	SELL	$11.05 - $12.72 $1.59 Million - $1.83 Million	-143,697 Reduced 5.21%	2,615,039 $30.2 Million
Q1 2022 May 13, 2022	SELL	$10.61 - $12.88 $51,267 - $62,236	-4,832 Reduced 0.17%	2,758,736 $34.7 Million
Q4 2021 Feb 11, 2022	SELL	$10.86 - $13.95 $519,498 - $667,312	-47,836 Reduced 1.7%	2,763,568 $32.2 Million
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $643,620 - $751,610	53,995 Added 1.96%	2,811,404 $36.7 Million
Q2 2021 Aug 13, 2021	SELL	$10.16 - $13.11 $192,369 - $248,224	-18,934 Reduced 0.68%	2,757,409 $35.5 Million
Q1 2021 May 12, 2021	BUY	$9.04 - $11.86 $2.73 Million - $3.58 Million	302,099 Added 12.21%	2,776,343 $31 Million
Q4 2020 Feb 12, 2021	BUY	$9.05 - $12.2 $1.06 Million - $1.42 Million	116,777 Added 4.95%	2,474,244 $28.2 Million
Q3 2020 Nov 13, 2020	SELL	$8.99 - $10.74 $535,893 - $640,211	-59,610 Reduced 2.47%	2,357,467 $21.2 Million
Q2 2020 Aug 13, 2020	BUY	$9.14 - $11.97 $1.14 Million - $1.49 Million	124,431 Added 5.43%	2,417,077 $24.9 Million
Q1 2020 May 14, 2020	BUY	$8.58 - $14.01 $845,627 - $1.38 Million	98,558 Added 4.49%	2,292,646 $23.1 Million
Q4 2019 Feb 13, 2020	BUY	$8.22 - $14.0 $271,950 - $463,176	33,084 Added 1.53%	2,194,088 $29.2 Million
Q3 2019 Nov 12, 2019	BUY	$8.59 - $10.96 $317,005 - $404,467	36,904 Added 1.74%	2,161,004 $18.6 Million
Q2 2019 Aug 14, 2019	BUY	$9.8 - $12.89 $1.78 Million - $2.35 Million	182,121 Added 9.38%	2,124,100 $23.2 Million
Q1 2019 May 14, 2019	BUY	$8.27 - $12.73 $2.34 Million - $3.61 Million	283,225 Added 17.07%	1,941,979 $26.3 Million
Q4 2018 Feb 13, 2019	BUY	$7.8 - $16.13 $736,733 - $1.52 Million	94,453 Added 6.04%	1,658,754 $17.2 Million
Q3 2018 Nov 13, 2018	BUY	$14.31 - $17.65 $2.01 Million - $2.48 Million	140,509 Added 9.87%	1,564,301 $28.9 Million
Q2 2018 Aug 14, 2018	BUY	$11.83 - $16.2 $1.67 Million - $2.29 Million	141,073 Added 11.0%	1,423,792 $27.2 Million
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $476,508 - $583,541	42,813 Added 3.45%	1,282,719 $19.8 Million
Q4 2017 Feb 13, 2018	BUY	$12.16 - $14.58 $375,756 - $450,536	30,901 Added 2.56%	1,239,906 $18.6 Million
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $169,511 - $208,834	14,044 Added 1.18%	1,209,005 $19.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,194,961	1,194,961 $22.6 Million

Others Institutions Holding IRWD

# of Institutions

237

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $682M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Ironwood Pharmaceuticals Inc Transaction History